This Article Full Text Full Text (PDF) All Versions of this Article: 115/15/2033    most recent CIRCULATIONAHA.106.668665v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sorokina, N. Articles by Lewandowski, E. D. Search for Related Content PubMed PubMed Citation Articles by Sorokina, N. Articles by Lewandowski, E. D. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB GLUCOSE PALMITIC ACID SODIUM PALMITATE Related Collections Biochemistry and metabolism Congestive Lipids Energy metabolism Gene expression Heart failure - basic studies Hypertrophy

(Circulation. 2007;115:2033-2041.)
© 2007 American Heart Association, Inc.

Molecular Cardiology

Recruitment of Compensatory Pathways to Sustain Oxidative Flux With Reduced Carnitine Palmitoyltransferase I Activity Characterizes Inefficiency in Energy Metabolism in Hypertrophied Hearts

Natalia Sorokina, PhD; J. Michael O’Donnell, PhD; Ronald D. McKinney, BS; Kayla M. Pound, BS; Gebre Woldegiorgis, PhD; Kathryn F. LaNoue, PhD; Kalpana Ballal, PhD; Heinrich Taegtmeyer, MD, DPhil; Peter M. Buttrick, MD; E. Douglas Lewandowski, PhD

From the Program in Integrative Cardiac Metabolism (N.S., J.M.O., K.M.P., E.D.L.) and Center for Cardiovascular Research (N.S., J.M.O., R.D.M., K.M.P., P.M.B., E.D.L.), University of Illinois at Chicago, College of Medicine, Chicago; Department of Environmental and Biomolecular Systems (G.W.), Oregon Health and Science University, Beaverton; Department of Molecular and Cellular Physiology (K.F.L.), Pennsylvania State University Medical School, Hershey; and Department of Internal Medicine (K.B., H.T.), Division of Cardiology, University of Texas Houston Medical School, Houston.

Correspondence to E. Douglas Lewandowski, PhD, Department of Physiology and Biophysics, MC901, UIC College of Medicine, 835 S Wolcott Ave, Chicago, IL 60612. E-mail dougl{at}uic.edu

Received October 5, 2006; accepted February 20, 2007.

Background— Transport rates of long-chain free fatty acids into mitochondria via carnitine palmitoyltransferase I relative to overall oxidative rates in hypertrophied hearts remain poorly understood. Furthermore, the extent of glucose oxidation, despite increased glycolysis in hypertrophy, remains controversial. The present study explores potential compensatory mechanisms to sustain tricarboxylic acid cycle flux that resolve the apparent discrepancy of reduced fatty acid oxidation without increased glucose oxidation through pyruvate dehydrogenase complex in the energy-poor, hypertrophied heart.

Methods and Results— We studied flux through the oxidative metabolism of intact adult rat hearts subjected to 10 weeks of pressure overload (hypertrophied; n=9) or sham operation (sham; n=8) using dynamic ¹³C–nuclear magnetic resonance. Isolated hearts were perfused with [2,4,6,8,10,12,14,16-¹³C₈] palmitate (0.4 mmol/L) plus glucose (5 mmol/L) in a 14.1-T nuclear magnetic resonance magnet. At similar tricarboxylic acid cycle rates, flux through carnitine palmitoyltransferase I was 23% lower in hypertrophied (P<0.04) compared with sham hearts and corresponded to a shift toward increased expression of the L–carnitine palmitoyltransferase I isoform. Glucose oxidation via pyruvate dehydrogenase complex did not compensate for reduced palmitate oxidation rates. However, hypertrophied rats displayed an 83% increase in anaplerotic flux into the tricarboxylic acid cycle (P<0.03) that was supported by glycolytic pyruvate, coincident with increased mRNA transcript levels for malic enzyme.

Conclusions— In cardiac hypertrophy, fatty acid oxidation rates are reduced, whereas compensatory increases in anaplerosis maintain tricarboxylic acid cycle flux and account for a greater portion of glucose oxidation than previously recognized. The shift away from acetyl coenzyme A production toward carbon influx via anaplerosis bypasses energy, yielding reactions contributing to a less energy-efficient heart.

---

 

CLINICAL PERSPECTIVE

This article has been cited by other articles:

				H. Tuunanen, E. Engblom, A. Naum, K. Nagren, M. Scheinin, B. Hesse, K.E. Juhani Airaksinen, P. Nuutila, P. Iozzo, H. Ukkonen, et al. Trimetazidine, a Metabolic Modulator, Has Cardiac and Extracardiac Benefits in Idiopathic Dilated Cardiomyopathy Circulation, September 16, 2008; 118(12): 1250 - 1258. [Abstract] [Full Text] [PDF]

				J. J. Lehman, S. Boudina, N. H. Banke, N. Sambandam, X. Han, D. M. Young, T. C. Leone, R. W. Gross, E. D. Lewandowski, E. D. Abel, et al. The transcriptional coactivator PGC-1{alpha} is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H185 - H196. [Abstract] [Full Text] [PDF]

				H. Ashrafian, M. P. Frenneaux, and L. H. Opie Metabolic Mechanisms in Heart Failure Circulation, July 24, 2007; 116(4): 434 - 448. [Abstract] [Full Text] [PDF]